Welcome to GlaxoSmithKline Pakistan
In focus:
The threat of typhoid
Typhoid is caused by the Salmonella typhi bacteria which live in humans. It is the fourth most common cause of death in Pakistan with 70% of all cases recorded in Asia alone. In Pakistan, the key modes of transmission for this bacterium include ice cream, eating from unhygienic roadside cabins, drinking contaminated water and taking antibiotics 2 weeks before the onset of symptoms.
The power of research
With our headquarters in the United Kingdom, GSK has operations in over 180 markets around the world. Patients today are doing more, feeling better and living longer - benefiting from many medical advances which include pharmaceutical research.
GSK facts
- GSK dedicated to Research and Development for 80 years
- Cost of bringing a medicine to market: $800 million (Rs 4.8 billion)
- Average length of time to discover new drug: 10-15 years
- 5 out of every 10,000 compounds investigated reach clinical trial phase and only 1 of those gets approved for patient use.
- GSK has industry's most extensive portfolio of R&D projects for diseases affecting developing countries
Updated March 2008 by GlaxoSmithKline Pakistan.
© 2007 GlaxoSmithKline - All rights reserved.
Legal notices | Privacy statement